Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) Patients

Clinical trial NCT01138111 · COMPLETED

Trial details

NCT number: NCT01138111
Sponsor: Lantheus Biosciences Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease Amyloid Beta-Protein

Start date: 2008-06-01
Primary completion: 2011-12-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.